Pd-Rx Pharmaceuticals Inc (OTC:PDRX)

WEB NEWS

Tuesday, December 27, 2022

Research

PD-Rx Pharmaceuticals, Inc. (OTC:PDRX) engages in the repackaging and distribution of prepackaged pharmaceutical products for the healthcare industry in the United States. In early December the company reported its full year 2022 results:

  • Sales of $28.7 million vs $21.6 million

  • EPS of $1.83 vs $1.08 

The annual report starts with a letter to shareholders which we encourage you to read for more color on the story. It should be noted that the company is dark, no filings or press releases are issued and its stock is extremely illiquid with an average volume of 600 shares per day and no visible bid/ask. 



Market Data powered by QuoteMedia. Terms of Use